Cecilia Gonzalo
Directeur/Membre du Conseil chez Edgemont Pharmaceuticals LLC
Profil
Ms. Cecilia Gonzalo is a Partner at Oberland Capital Management LLC, an Independent Director at Melinta Therapeutics, Inc. and a Treasurer & Director at Harvard Business School Health Industry Alumni Association.
She is on the Board of Directors at Edgemont Pharmaceuticals LLC, Melinta Therapeutics, Inc., ImmusanT, Inc. and Harvard Business School Health Industry Alumni Association.
Ms. Gonzalo was previously employed as a Managing Director by Vatera Holdings LLC, a Managing Director by Essex Woodlands Management, Inc., an Independent Director by Allos Therapeutics, Inc., an Independent Director by Melinta Subsidiary Corp., an Independent Director by Melinta Therapeutics, Inc., a Partner by Warburg Pincus & Company US LLC, a Managing Director by Warburg Pincus LLC, an Analyst by Goldman Sachs Asset Management LP, and a Researcher by Harvard Medical School.
She also served on the board at Talon Therapeutics, Inc., Eurand NV, GANIC Pharmaceuticals, Inc., LaVie Care Centers LLC and Prestwick Pharmaceuticals, Inc.
She received her undergraduate degree from Harvard College and an MBA from Harvard Business School.
Postes actifs de Cecilia Gonzalo
| Sociétés | Poste | Début |
|---|---|---|
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Directeur/Membre du Conseil | 01/01/2016 |
| Harvard Business School Health Industry Alumni Association | Directeur/Membre du Conseil | - |
Oberland Capital Management LLC
 Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Private Equity Investor | 01/11/2018 |
Anciens postes connus de Cecilia Gonzalo
| Sociétés | Poste | Fin |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2018 |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Private Equity Investor | 31/03/2013 |
Warburg Pincus & Company US LLC
 Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Corporate Officer/Principal | 31/03/2013 |
| MELINTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2012 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Directeur/Membre du Conseil | 05/09/2012 |
Formation de Cecilia Gonzalo
| Harvard College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Finance |
Goldman Sachs Asset Management LP
 Goldman Sachs Asset Management LP Investment ManagersFinance Goldman Sachs Asset Management LP (GSAMLP) is a SEC-registered investment advisor headquartered in New York City. The firm is a wholly owned subsidiary of GSAM Holdings LLC, and their ultimate parent is Goldman Sachs Group, Inc. (NYSE: GS). Founded in 1988, GSAMLP provides investment solutions to a range of individual and institutional investors worldwide. | Finance |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
LaVie Care Centers LLC
 LaVie Care Centers LLC Medical/Nursing ServicesHealth Services Part of Consulate Management Co., LLC, LaVie Care Centers LLC is a company that offers a range of services including comprehensive short-term rehabilitation, transitional care, Alzheimer's and dementia care, long-term care, and assisted and independent living. The company is based in Maitland, FL. The company focuses on creating rigorous systems of care and deploying technology to better understand patient needs. | Health Services |
Warburg Pincus & Company US LLC
Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Finance |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Eurand NV develops pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. The company was founded in 1984 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
GANIC Pharmaceuticals, Inc.
 GANIC Pharmaceuticals, Inc. Drugstore ChainsRetail Trade GANIC Pharmaceuticals develops and markets pharmaceutical products. The firm is focused on building fully-integrated pharmaceuticals enterprise focused on certain specialty areas. The company was founded in 2008 and is headquartered in Bridgewater, NJ. | Retail Trade |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Health Technology |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Finance |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Oikos Holdings LLC is a financial advisory services holding private company. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Kevin Thomas Ferro. | Finance |
| Harvard Business School Health Industry Alumni Association | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Oberland Capital Management LLC
Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Finance |
